MedMira (TSXV:MIR) Change In Payables And Accrued Expense : C$0.02 Mil (TTM As of Jul. 2024)

View and export this data going back to 1999. Start your Free Trial

What is MedMira Change In Payables And Accrued Expense?

MedMira's Change In Payables And Accrued Expense for the quarter that ended in Jul. 2024 was C$0.53 Mil. It means MedMira's Accounts Payable & Accrued Expense increased by C$0.53 Mil from Apr. 2024 to Jul. 2024 .

MedMira's Change In Payables And Accrued Expense for the fiscal year that ended in Jul. 2024 was C$0.02 Mil. It means MedMira's Accounts Payable & Accrued Expense increased by C$0.02 Mil from Jul. 2023 to Jul. 2024 .

MedMira Change In Payables And Accrued Expense Historical Data

The historical data trend for MedMira's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Change In Payables And Accrued Expense Chart

MedMira Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.17

1.07

0.46

1.10

0.02

MedMira Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.13	-0.03	-0.03	-0.44	0.53

MedMira Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02 Mil.

MedMira Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of MedMira's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (TSXV:MIR) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MMIRF:USA 47M:Germany 47M:Germany

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.